Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SATIN: Larotaxel vs Docetaxel in High Risk Localized Breast Cancer
NCT00485979Phase 2Completed
- Sponsor
- Sanofi
- Start
- Jun 2007
- Primary completion
- Aug 2010
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 2 trial of larotaxel in breast cancer, sponsored by Sanofi. Started Jun 2007; status: completed.
02
Drugs
larotaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00485979.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00485979.